HomeRNAC • NASDAQ
add
Cartesian Therapeutics Inc
Previous close
$22.64
Day range
$23.00 - $25.38
Year range
$11.67 - $42.60
Market cap
434.76M USD
Avg Volume
94.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 26.00M | -76.30% |
Operating expense | 39.30M | 72.40% |
Net income | -211.95M | -622.48% |
Net profit margin | -815.05 | -2,305.22% |
Earnings per share | — | — |
EBITDA | -77.39M | -467.76% |
Effective tax rate | 8.23% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 76.91M | -42.86% |
Total assets | 305.05M | 83.89% |
Total liabilities | 444.68M | 517.11% |
Total equity | -139.63M | — |
Shares outstanding | 5.40M | — |
Price to book | -0.28 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -211.95M | -622.48% |
Cash from operations | -44.66M | -49.99% |
Cash from investing | 34.66M | 333.38% |
Cash from financing | -14.57M | -137.15% |
Net change in cash | -24.62M | -356.76% |
Free cash flow | — | — |
About
Founded
2007
Headquarters
Website
Employees
38